Published in Vaccine Weekly, June 16th, 2010
SGI and its founders are world leaders in the design and construction of synthetic genomes, where DNA can be assembled in the laboratory and used to create or modify cells and whole genomes. Synthetic biology can have applications across a number of fields, from the development of new sources of fuel, to products such as new vaccines that will improve human health.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-06-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.